HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T cell immunoglobulin and mucin domain-containing molecule 3 on CD14+ monocytes serves as a novel biological marker for diabetes duration in type 2 diabetes mellitus.

AbstractAIMS/INTRODUCTION:
Type 2 diabetes is a worldwide disease that is associated with increased rates of obesity and reduced physical activity. Obesity-associated insulin resistance in type 2 diabetes is a disorder in the balance between pro-inflammatory and anti-inflammatory signals. T cell immunoglobulin and mucin domain-containing molecule 3 (Tim-3) has been reported as an important regulatory inflammation molecule, and plays a pivotal role in several inflammation-related diseases.
MATERIALS AND METHODS:
Peripheral blood mononuclear cells were obtained from type 2 diabetes patients (n = 31) and healthy donors (n = 18), and Tim-3 expression on peripheral blood mononuclear cells was evaluated by flow cytometry.
RESULTS:
We showed the downregulated expression of Tim-3 on CD14+ monocytes from type 2 diabetes patients. In addition, the upregulated expression of Tim-3 on peripheral CD4+ T cells and CD8+ T cells was observed in the present study. The correlation analysis between Tim-3 expression on CD14+ monocytes and diabetes duration showed the longer diabetes duration time, the lower Tim-3 expression on CD14 monocytes.
CONCLUSIONS:
The present results suggest that Tim-3 might participate in the progression of type 2 diabetes by its negative regulation on these immune cells, and Tim-3 on CD14+ monocytes serves as a novel biological marker for diabetes duration in type 2 diabetes patients.
AuthorsWen-Jiang Yan, Peng Sun, Dan-Dan Wei, Shuang-Xi Wang, Jing-Jing Yang, Yi-Hui Li, Cheng Zhang
JournalJournal of diabetes investigation (J Diabetes Investig) Vol. 7 Issue 6 Pg. 867-873 (Nov 2016) ISSN: 2040-1124 [Electronic] Japan
PMID27182056 (Publication Type: Journal Article)
Copyright© 2016 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.
Chemical References
  • Biomarkers
  • CD4 Antigens
  • CD8 Antigens
  • HAVCR2 protein, human
  • Hepatitis A Virus Cellular Receptor 2
  • Lipopolysaccharide Receptors
Topics
  • Adult
  • Aged
  • Biomarkers (metabolism)
  • CD4 Antigens (metabolism)
  • CD8 Antigens (metabolism)
  • Diabetes Mellitus, Type 2 (diagnosis, immunology, metabolism)
  • Disease Progression
  • Female
  • Hepatitis A Virus Cellular Receptor 2 (metabolism)
  • Humans
  • Lipopolysaccharide Receptors (metabolism)
  • Male
  • Middle Aged
  • Monocytes (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: